RUA Life Sciences (LON:RUA) Stock Price Up 9.2% – Should You Buy?

RUA Life Sciences plc (LON:RUAGet Free Report)’s stock price was up 9.2% on Monday . The company traded as high as GBX 12.90 ($0.16) and last traded at GBX 12.20 ($0.15). Approximately 546,121 shares changed hands during mid-day trading, an increase of 97% from the average daily volume of 277,876 shares. The stock had previously closed at GBX 11.17 ($0.14).

RUA Life Sciences Stock Performance

The company has a debt-to-equity ratio of 5.42, a quick ratio of 7.32 and a current ratio of 9.01. The company has a market cap of £7.57 million, a P/E ratio of -305.00 and a beta of 1.21. The firm has a 50 day moving average price of GBX 11.11 and a 200-day moving average price of GBX 11.51.

RUA Life Sciences Company Profile

(Get Free Report)

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.

Further Reading

Receive News & Ratings for RUA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RUA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.